glp 1 drugs and alzheimer's GLP-1 Disease: Research on Neuroprotective Potential GLP-1 Drugs May Help Prevent

Theres no such thing as GLP-3. GLP-2 exists, but retatrutide has nothing to do with it

Future research should prioritize long-term safety assessments, efficacy evaluations in specific populations, exploration of novel indications (eg, metabolic-associated fatty liver disease and obstructive sleep apnea), and mechanistic studies to enhance the therapeutic utility of these agents in metabolic and related diseases (See Figure 7)

Association of Metabolic Syndrome and Other Factors with the Presence of Diabetic Nephropathy in Type 2 Diabetic Patients

Food and Drug Administration (FDA-d)

It really depends on what injectable option we are transitioning from, but generally, or in most cases, Id expect increased hunger and some weight [regain], he says